Immix Biopharma (IMMX) Current Assets (2020 - 2026)

Quarterly results put Current Assets at $92.3 million for Q1 2026, up 449.93% from a year ago — trailing twelve months through Mar 2026 was $92.3 million (up 449.93% YoY), and the annual figure for FY2025 was $101.2 million, up 401.23%.

Immix Biopharma has reported Current Assets over the past 7 years, most recently at $92.3 million for Q1 2026.

  • Current Assets reached $92.3 million in Q1 2026 per IMMX's latest filing, down from $101.2 million in the prior quarter.
  • Across five years, Current Assets topped out at $101.2 million in Q4 2025 and bottomed at $12.3 million in Q2 2025.
  • Median Current Assets over the past 5 years was $19.8 million (2023), compared with a mean of $28.5 million.
  • The largest annual shift saw Current Assets tumbled 54.9% in 2025 before it skyrocketed 449.93% in 2026.
  • Over 5 years, Current Assets stood at $14.9 million in 2022, then skyrocketed by 32.82% to $19.8 million in 2023, then rose by 2.07% to $20.2 million in 2024, then soared by 401.23% to $101.2 million in 2025, then dropped by 8.85% to $92.3 million in 2026.
  • Business Quant data shows Current Assets for IMMX at $92.3 million in Q1 2026, $101.2 million in Q4 2025, and $16.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 10.37 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 37.31 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 1.25 Bn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 73.04 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 3.59 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 11.73 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 18.21 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 4.22 Bn
10 Immix Biopharma 476.17 Mn 476.17 Mn - 92.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 92.27 Mn
Dec 31, 2025 101.24 Mn
Sep 30, 2025 16.58 Mn
Jun 30, 2025 12.33 Mn
Mar 31, 2025 16.78 Mn
Dec 31, 2024 20.20 Mn
Sep 30, 2024 22.76 Mn
Jun 30, 2024 27.33 Mn
Mar 31, 2024 32.92 Mn
Dec 31, 2023 19.79 Mn
Sep 30, 2023 22.33 Mn
Jun 30, 2023 15.51 Mn
Mar 31, 2023 13.03 Mn
Dec 31, 2022 14.90 Mn
Sep 30, 2022 17.39 Mn
Jun 30, 2022 19.08 Mn
Mar 31, 2022 20.01 Mn
Dec 31, 2021 18.19 Mn
Dec 31, 2020 532,236.00